Clenil 2Ml Compositum For Aerosol 0.8Mg+1.6Mg (1 Box = 10 Nebulization Solution)
Salbutamol: Salbutamol is a selective ß2-adrenoceptor agonist
Salbutamol: Salbutamol is a selective ß2-adrenoceptor agonist. At therapeutic doses it acts on the ß2-adrenoceptors of bronchial muscle providing short acting (4-6 hours) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. Beclomethasone dipropionate: Beclomethasone dipropionate is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclomethasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity .
Purpose
Asthma
Ingredients
Beclomethasone Dipropionate , Salbutamol
Warnings
In the event of a previously effective dose of inhaled salbutamol failing to give relief for at least three hours, the patient is advised to be advised to seek medical advice in order that any necessary additional steps may be taken.
Cardiovascular effects may be seen with sympathomimetic drugs, including salbutamol. Patients with underlying severe heart disease (e.g., ischemic heart disease, arrhythmia or severe heart failure) whoare receiving salbutamol is advised to be warned to seek medical advice if they experience chest pain or other symptoms of worsening heart disease.
Increasing use of short-acting inhaled ß2-agonists to control symptoms indicates deterioration of asthma control. Consideration is advised to be given to starting or increasing corticosteroid therapy.
Side Effects
Salbutamol: Tremor, headache, tachycardia, palpitations, mouth and throat irritation, muscle cramps, hypokalemia, peripheral vasodilatation, hypersensitivity reactions including angioedema, urticaria, bronchospasm, hypotension and collapse, hyperactivity, cardiac arrhythmias (including atrial fibrillation, supraventricular tachycardia and extrasystoles), paradoxical bronchospasm, myocardial ischemia.Beclomethasone dipropionate: Adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract, glaucoma, paradoxical bronchospasm with an immediate increase in wheezing, shortness of breath and cough after dosing, hypersensitivity reactions including rashes, urticaria, pruritus, erythema, oedema of the eyes, face, lips and throat, candidiasis of the mouth and throat, hoarseness or throat irritation, psychiatric disorders including psychomotor hyperactivity, sleep disorders, anxiety, depression, aggression and behavioural changes (predominantly in children).
Storage Instructions
Store this medicine at room temperature, away from direct light and heat.
| Brand | Chiesi |
| Status | Active |
Related Products
